MATERIALS AND METHODS
During normal deliveries, umbilical cord blood ( 5 to 8 mL) was collected in sterile vessels containing sodium-heparin (20 IU/mL). Light-density mononuclear cells were individually isolated from 18 cord blood samples by Ficoll-Paque (Pharmacia, Uppsala, Sweden) gradient separation at a density of 1.077 g/mL. Mononuclear cells were depleted of adherent cells by incubation on plastic Petri dishes for 1 hour at 37OC. Thus, the nonadherent cells isolated were used for the establishment of cell lines.
Two different preparations of rhIL-3 were used. The first preparation was obtained from Genzyme Corp (Boston, MA) and used mainly for the establishment of cell lines. The specific activity of this IL-3 preparation (GhIL-3) has been determined to be 10' U/mg of protein (one unit is defined as the amount to produce a single colony from 7.5 x lo4 human bone marrow cells in the soft agar assay). The second preparation of rhIL-3 was isolated from Escherichia coli cells harboring an expression plasmid containing the hIL-3 gene. This gene was synthesized by an automated DNA synthesizer (Applied Biosystems Model 38 1 A, Tokyo, Japan), through successive ligation of 17 oligonucleotides of 30-62 bases that were designed to contain frequently occurring codons in E coli." The gene (413 base pairs [bp]) was inserted into an E coli plasmid downstream from the trp promoter. This recombinant plasmid was then transfected into E coli cells, from which rhIL-3 was produced on induction by 3-indolylacrylic acid at an early logarithmic phase. The rhIL-3 was purified from E coli cell pellets by a series of purification steps that included isolation of inclusion bodies by Percoll gradient centrifugation, solubilization of rhIL-3 with 7 mol/L urea, and separation by DEAE column chromatography. Thus, the rhIL-3 obtained was found to be homogeneous by sodium Human cells.
rhlL-3.
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis. By using KMT-2 cells and Genzyme rhIL-3 as the control, we determined the specific activity of purified rhIL-3 to be 5 x lo7 U/mg of protein in proliferation assay.
Radiolabeling of rhIL-3 with "' 1 was done with a modified rhIL-3 containing an additional octapeptide, Met-Tyr-(His), at the N-terminus. The octapeptide was introduced by replacing the nucleotide sequence atcgatATG GCGC to atcgatATG TAC CAT CAC CAT CAC CAT CAC GCG C. This modified rhIL-3 (rhIL-3-Y) was then produced in E coli and purified as described previously. The rhIL-3-Y (5 x lo7 U/mg) from E coli was radiolabeled by the radioiodination reagent kit (New England Nuclear, Boston, MA) essentially as described in the instructions. In brief, 10 pg of rhIL-3-Y was dissolved in phosphate-buffered saline (PBS), then 100 pL of radioiodination reagent (lactoperoxidase and glucose oxidase-coupled beads), 10 pL of (2 mCi), and 25 pL of 1% 8-D-glucose were added. The mixture was incubated at room temperature for 30 minutes and the reaction was terminated with 10 pL of sodium metabisulfite (10 mg/mL). Then, iodinated rhIL-3-Y was separated from free "' I by gel-filtration on a 91-mL Sephadex (3-25 (Pharmacia, Uppsala, Sweden) column equilibrated with PBS solution containing 1 mg/mL bovine serum albumin (BSA) and 0.05% sodium azide (binding medium). Fractions containing iodinated protein were pooled and used as a radiolabeled preparation of rhIL-3 (I2'I-rhIL-3). The specific activity of this preparation was usually 1.7 x 10'' cpm/mmol/L, as estimated based on the initial molar concentration of the protein determined by its amino acid composition.
rhIL-la (3 x 10' U/mg protein) was provided by Dr P. Lomedico (Hoffmann La Roche, Nutley, NJ). Recombinants of human IL-2 (2 x 10' U/mg protein), IL-4 (-10' U/mg protein), IL-6 (lo7 U/mg protein), and granulocytemacrophage CSF (GM-CSF, 5 x lo7 U/mg protein) were obtained from Genzyme. hIL-5 was a gift from Dr K. Takatsu (Kumamoto University, Japan). Conditioned medium from COS-7 cells transfected with cDNA coding for hIL-5 was used. This conditioned medium supported the maximum growth of eosinophiles (an IL-5 assay) in a dilution of 1:lO. Erythropoietin purified from human urine (49 U/mg protein) was purchased from Toyobo Co, LTD (Osaka, Japan).
Cytospin slide preparations of the cell suspension were prepared with a Shandon cytospin centrifuge (Shandon Southern Product, Sewickly, PA) and subjected to May-Grunwald Giemsa staining. Cells were also stained for acid phosphatase and peroxidase activity, as well as with Sudan black B and periodic acid Schiff stains. a-Naphtyl butyrate and AS-D chloroacetate esterase dual staining was performed." Cytogenetic analysis was performed with trypsin Giemsa banding techniques." Forty cells in metaphase were analyzed.
Cell surface phenotyping and cell sorting were performed on an EPICS-C flow cytometer (Coulter Electronics Inc, Hialeah, FL). Indirect immunofluorescence staining was done according to standard techniques with various murine monoclonal antibodies (MoAbs) and fluorescein isothiocyanate (F1TC)-conjugated goat F(ab'), anti-mouse IgG (Cappel, West Chester, PA). In some cases, direct staining was performed with murine MoAbs conjugated with FITC. MoAbs used were obtained from Becton Dickinson (Paramus, NJ).
Proliferation assay. Cells were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, 60 pg/mL kanamycin, 2 mmol/L L-glutamine, 1 mmol/L sodium pyruvate, and 50 pmol/L 2-mercaptoethanol (the growth medium) at a density of 5 x IO4 cells/mL in an atmosphere of air plus 5% CO, at 37°C for 3 days. Various growth factors were added alone or in combination The specific binding of 12SI-rhIL-3 to KMT-2 cells was evaluated by a phthalate oil separation method as described for mouse IL-3." After incubation in an rhIL-3-free culture medium for 20 hours, the cells were washed and suspended in cold RPMI 1640 containing 10 mg/mL BSA, 25 mmol/L HEPFS (pH 7.2), 0.05% NaN, (binding buffer) at a density of lo6 cells/50 pL. Binding of "'I-rhIL-3 to cells was measured with and without unlabeled rhIL-3 or rhGM-CSF at 37OC for 2 hours. The amounts of unlabeled growth factors used were described in each figure legend.
After incubation for 20 hours in culture medium without rhIL-3, KMT-2 cells were suspended in the binding buffer containing I2'I-rhIL-3 (1.75 x 10' cpm). Control assays with a 100-fold excess of unlabeled IL-3 were performed in parallel to assay for nonspecific binding. The cells were incubated for 3 hours at 4°C and were pelleted by centrifugation. The pelleted cells were washed and resuspended in cold PBS containing 1 mmol/L Disuccinimidyl suberate (DSS, Pierce Chemical Co, Rockford IL). After a 30-minute incubation at room temperature, the reaction was stopped by the addition of 0.5 mol/L Tris-HC1, pH 7.2. Membranes were extracted with 100 pL of a 1% Nonidet P-40 (Nacarai Tesque Inc, Kyoto, Japan) containing 1 mmol/L phenylmethyl sulfonyl fluoride (Calbiochem-Behring Corp, La Jolla, CA). Extracts were added of an equal volume consisting of 2% SDS, 10% 2-mercaptoethanol, 20% glycerol, 125 mmol/L Tris-HCI, pH 6.8 (SDS-sample buffer), and were boiled for 5 minutes for SDS-PAGE.
SDS-PAGE and autoradiography. Samples were electrophoresed on 7.5% polyacrylamide gels together with molecular weight markers from Bio-Rad Laboratories (Richmond, CA). The gels were dried and Kodak X-OMAT film (Rochester, NY) was exposed at -8OOC.
ZL-3 receptor binding assays.
Cross-linking assay.
RESULTS

Establishment of hIL-3-responsive cell lines f r o m umbil-
ical cord blood cells. Nonadherent cells isolated from human umbilical cord blood were suspended in the growth medium and seeded at lo5 cells/well in 96-well tissue culture plates. GhIL-3 (0.8,4,20, or 100 U / m L ) and rhIL-3 (8,40, 200, or 1,000 ng/mL, our preparation) were added to the cells, which were then cultured. By removing one half of the medium and adding an equal volume of fresh medium containing each one of the above concentrations of rhIL-3, we fed each culture a t 2-to 3-day intervals. In about 1 month the cells growing in response to GhIL-3 or rhIL-3 were gradually scaled u p to 24-well and then 12-well plates, and were then finally cultured in flasks. For direct cloning, the cells were cultured in growth medium containing 0.3% agar and rhIL-3 (20 ng/mL) at a density of 5 x lo3 cells/well in a 24-well tissue culture plate, as described by Tzartos et alzi; colonies formed on the above soft agar were individually transferred by Pasteur pipettes to 96-well plates and then cultured again in liquid medium containing rhIL-3, which was gradually scaled u p to 24-well and then 12-well plates, and finally cultured in flasks. From a total of 2,300 wells of the culture ( 105/well), 660 colonies were obtained. The colonies were individually transferred to liquid medium and cultured with gradual scaling u p as described above. During Fig 1) were collected and cultured in the presence of rhlL-3 with gradual scaling up. Thus, three cell lines were established; however. the growth of two had declined during 3 months of subculturing. Finally, a line of hlL-3-responsive cells. designated as KMT-2. was established. and this has been subcultured for 23 months after recloning.
In the May-Granwald Giemsa-stained preparation. KMT-2 cells have a large nucleus with one or two marked nucleoli and few azurophilic granules in basophilic cytoplasm (Fig 2A) . Specific staining for acid phosphatase and periodic acid SchitT proved positive. while myeloperoxidase. A S D chloroacetate esterase. and Sudan black staining were negative in this cell line. Some of cells were significantly positive for a-naphtyl butylate esterase. which was inhibited by sodium fluoride (Fig 2R) . Cytogenetic analysis of KMT-2 cells demonstrated abnormal karyotypes: the modal chromosomal number was 45 and most of the cells had double minutes.
To assess factor-depndency. the cells were tested for their proliferation in various growth factors. Figure 3 shows the growth curves of KMT-2 cells cultured with 100 U/mL of rhlL-3. rhGM-CSF. or rhM-CSF after preincubation in faaor-free culture medium for 20 hours. In the presence of rhlL-3 or rhGM-CSF. the cells showed significant thymidine uptake Culture Period (Hour)
Growth curves of KMT-2 cells. Cells were cultured at a density of 10' cells/mL in the absence (0) and presence (100 U/mL) of rhlL-3 (0). GM-CSF (A), or M-CSF ( 0 ) after preincubation in factor-free culture medium for 20 hours. Proliferation was determined by 'H-thymidine uptake (with 5 pCi/mL for the last 3 hours) at the days indicated.
over the culture period tested. The cells cultured with rhM-CSF or medium alone (containing 10% of fetal calf serum) increased their thymidine uptake after some lag time. KMT-2 cells were further examined for their responsiveness to IL-la, IL-2, IL-4, IL-5, IL-6, GM-CSF, and erythropoietin either alone or in combination with IL-3. As shown in Fig 4 , IL-la, IL-2, IL-4, IL-5, and erythropoietin did not stimulate the proliferation. They also did not interfere with the stimulating activity of 1L-3 when examined in combination with IL-3. These results suggest that there is no receptor for IL-la, IL-2, IL-4, IL-5, or erythropoietin on the KMT-2 cells. IL-6 had only weak activity at high concentrations. GM-CSF supported dose-dependently the growth of KMT-2 cells, though less effectively than IL-3 did. Figure 5 shows the growth supported by a combination of GM-CSF or IL-6 with IL-3. GM-CSF and IL-6 exerted additive effects at low doses of IL-3 but not additive at high doses of IL-3. At saturating levels of IL-3 (1 to 100 U/mL), neither GM-CSF nor IL-6 affected the growth supported by IL-3. These results indicate that some interactions occur with GM-CSF or IL-6 on IL-3-mediated signal transduction.
The binding of I2'I-rhIL-3 to the KMT-2 cells was examined at 37OC. As shown in cell lines that were subjected to the receptor studies. Thus, we tried to identify the IL-3 receptor molecule using this cell line. Cross-linking of '251-labeled rhIL-3 to KMT-2 cells was performed by using DSS, yielding three radiolabeled com- plexes with molecular sizes of 185. 145. and 85 Kd on SDS-PAGE and autoradiography (Fig 7) . The binding of '"I-rhlL-3 to the cell receptors and formation of the crosslinked complexes were prevented with a 100-fold excess of unlabeled rhlL-3. After subtracting out the molecular mass of rhlL-3-Y (IS.OOO), the mass of the receptors or its subunits are roughly estimated to be 170. 130. and 70 Kd.
Finally, we tested whether GM-CSFcan inhibit binding of "'I-rhlL-3 on these cells. Figure 8 shows that GM-CSF This line of cells proliferated well in the presence of rhlL-3. hGM-CSF also stimulated the growth of these cells. though lcss effectively than IL-3 did. However. hlL-la. IL-2. IL-4. and IL-5 had no effect on the proliferation of this cell line. Erythropoietin was also inactive. The nonresponsiveness of KMf-2 cells to erythropoietin or IL-5 was characteristically different from a multi-factor-dependent human cell line, TF-I. which was recently established from the bone marrow cells of a patient with erythroleukemia." IL-6 showed only slight enhancing activity. The effect of GM-CSF or IL-6 was additive with that of IL-3 at low levels of IL-3. However. at saturating levels of IL-3. neither GM-CSF nor IL-6 affected the growth supported by IL-3. indicating that these factors are effective only when the cells are maintained in a suboptimal concentration of IL-3. Santoli et al" have also reported that IL-3 enhanccd the GM-CSFdependent growth of early T-lymphoblastic leukemia (TALL-101) and of monocytic leukemia (AML-193) cells when GM-CSFand IL-3 were used at very low concentrations. We radiolabeled hIL-3 with Iz5I by using modified rhIL-3 containing a second tyrosine residue at the N-terminus, and found it to have high specific activity (1.7 x lOI5 cpm/mmol/ L). Iodination of this additional tyrosine residue was crucial for obtaining the radiolabeled molecule with a specific activity sufficiently high enough to allow for reproducible binding experiments, as described in the report by Park et aLZ5 Scatchard analysis of the binding experiments with IZ5I-rhIL-3 demonstrated the existence of about 4,000 binding sites per cell with a dissociation constant (kd) of -200 pmol/L. This result indicates that the KMT-2 cells express a higher number of IL-3 receptors than the other human cell lines reported so far: 175 to 310 sites/cell for the KG-1 cells and the other le~kemia,*~*'~ or 60 to 210 sites/cell for leukemic B-cell precursors,*' estimated by the binding of L251-labeled rhIL-3 containing additional peptide, Asp-TyrLys-(Asp),-Lys, or '?3-labeled rhIL-3, respectively. Because the radioligand reagent used in the above binding assays was not the same, it may be premature to conclude that KMT-2 cells possess the highest number of IL-3 receptors among the human cell lines assayed so far. Nevertheless, it has been shown that KMT-2 cells possess a sufficient number of IL-3 receptors to allow for its molecular characterization. The cross-linking of radiolabeled IL-3 to KMT-2 cells showed radiolabeled complexes with molecular sizes of 185, 145, and 85 Kd by autoradiography. Unlabeled rhIL-3 prevented the formation of all three complexes. After subtracting out the molecular mass of rhIL-3-Y (1 5,000), 170, 130, and 70 Kd were estimated for the IL-3 receptors or receptor subunits. Interestingly, these values are very similar to those estimated for the mouse IL-3
The newly established human cell line that expresses a large number of IL-3 receptors will facilitate the investigation of the signal transduction of human IL-3 and would be a useful tool for the purification of human IL-3 receptors.
